Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

September 13, 2019

Study Completion Date

September 13, 2019

Conditions
Porphyrias
Interventions
OTHER

Web-based Survey

"Participants will be directed to online forms to report general information (ex. age, sex, test results, family history), suspected medication-related acute attacks, and uneventful use of possibly risky medication. If a patient has multiple medication-related acute attacks, the patient/caregiver will be able to submit multiple report forms that will be linked. In addition to the report forms, patients will be asked to review a list of Medications of Interest and report current or past use."

Trial Locations (1)

33612

University of South Florida Data Management Coordinating Center, Tampa

All Listed Sponsors
collaborator

University of Texas

OTHER

collaborator

Wake Forest University Health Sciences

OTHER

collaborator

University of Miami

OTHER

collaborator

University of Washington

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

University of California, San Francisco

OTHER

collaborator

University of Utah

OTHER

collaborator

National Institutes of Health (NIH)

NIH

lead

University of South Florida

OTHER

NCT03906214 - Evidence-based Assessment of Medication Sensitivity in Acute Hepatic Porphyria | Biotech Hunter | Biotech Hunter